 RAMSEY, N.J. and BOCA RATON, Fla., Sept. 02, 2020 GLOBE NEWSWIRE -- ADMA Biologics, Inc. Nasdaq: ADMA ADMA or the Company, an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced that Adam Grossman, President and Chief Executive Officer, is scheduled to participate in the following upcoming investor conferences in September: 